Shirley’s practice is focused on corporate finance and commercial transactions. She regularly advises on mergers and acquisitions, public offerings, regulatory and compliance issues, as well as general corporate and commercial matters.

Shirley is experienced in assisting clients from China Mainland, Hong Kong, multinationals enterprises as well as leading investment banks and financial institutions on corporate and securities related matters. She also assisted listed companies on various transactional and regulatory compliance with applicable laws and regulations including the Hong Kong Listing Rules.

Shirley has provided legal services in the following cases:

• Advising Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) on the Hong Kong law aspects of it’s proposed A share offering as company legal counsel
• Advising Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) on its issuance of capitalization shares as company legal counsel
• Acting for China Traditional Chinese Medicine Holdings Co. Limited (Stock Code: 570) on its issuances of super & short commercial paper and medium-term notes as issuer’s Hong Kong legal counsel
• Acting for an American infant and toddler toy and product manufacturer in the re-financing of several cross-jurisdictional revolving facilities of up to US$108,000,000 as the borrower’s Hong Kong counsel
• Acting for leading global manufacturer and supplier of high-quality application specific standard products of several cross-jurisdictional facility agreements of up to US$690,000,000 as the borrower’s Hong Kong counsel
• Acting for an independent global automotive supplier of innovative and energy efficient powertrains of a cross-jurisdictional facility agreement of EUR350,000,000 as the borrower’s Hong Kong counsel
• Acting for the investing subsidiary held by one of the largest Chinese commercial banking groups on its issuances of medium-term notes as the issuer’s Hong Kong legal counsel
• Advising a bank consortium with 30 member banks in Hong Kong and Macau in relation to its share buy-back and public bidding as company legal counsel
• Advising China Tianrui Automotive Interiors Co., LTD (Stock Code: 6162) as the issuer counsel on its IPO
• Advising Huakang Biomedical Holdings Company Limited (Stock Code: 8622) as the issuer counsel on its IPO
• Acting as legal counsel to a PRC financial guarantee company and advising on the application and submission to list on the Hong Kong Stock Exchange Main Board
• Advising a leading logistics and transportation company on the acquisition of 51% equity interests of a logistics group and the formation of joint ventures in various jurisdictions in Asia Pacific
• Advising China Everbright as the sole sponsor and underwriter counsel on the IPO of China Shun Ke Long Holdings Limited (Stock Code: 0974)
• Advising Rakuten Securities on its acquisition of FXCM Asia Limited (a SFC Type 3 licensed company - leveraged foreign exchange trading)
• Advising Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) as the issuer counsel on its H-share IPO
• Advising Guangdong Alpha Animation and Culture Company Limited (SZSE Stock Code: 2292) on its acquisition of 100% interests in Infoport Management Limited and its related operations (Pleasant Goat and Big Big Wolf brand – being the number one cartoon brand in China) from Imagi International Holdings Limited (HKEx Stock Code: 585)
• Advising CITIC Real Estate (Hong Kong) Development Limited on its acquisition of 27% interests in the Guangzhou Huadu Ziyouren real estate project held by Nan Hai Corporation Limited (HKEx Stock Code: 680)
• Advising China Merchants Holdings (International) Company Limited (HKEx Stock Code: 144) on its formation of port joint venture in Port de Djibouti S.A. with the Republic of Djibouti
• Advising China Merchants Holdings (International) Company Limited (HKEx Stock Code: 144) on its formation of joint venture in Colombo International Container Terminals Limited in Sri Lanka